Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
cancer vaccine
|
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
nan
|
| gptkbp:clinicalTrialOutcome |
failed to meet primary endpoints
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:contains |
plasmid DNA
HLA-B7 gene beta-2 microglobulin gene |
| gptkbp:developedBy |
Vical Incorporated
|
| https://www.w3.org/2000/01/rdf-schema#label |
Allovectin-7
|
| gptkbp:intendedUse |
treatment of melanoma
|
| gptkbp:mechanismOfAction |
induces immune response against tumor cells
|
| gptkbp:routeOfAdministration |
intratumoral injection
|
| gptkbp:status |
development discontinued
|
| gptkbp:UNII |
nan
|
| gptkbp:bfsParent |
gptkb:Vical
|
| gptkbp:bfsLayer |
8
|